VENUS REMEDIES LTD
RESULTS FOR QUARTER ENDED DEC,13
Venus Remedies has performed satisfactorily in Q3 FY
13-14. The results are in the Table below.
Net Sales has increased by 4.57% QoQ and 16.66% YoY.
Net Profits have increased by 14.88 % QoQ
and By 7.31 % YoY.
Basic EPS was Rs.15.06
in Q3 ; Rs.13.11 in Q2; Rs.13.38 in Q1; Rs.11.34 in Q4 FY 13;and Rs.16.48 in Q3
FY 13.
Venus Remedies has Huge number of Patents and approvals
from many countries on hand and many new discoveries in the pipe line.
But, all these are not translating fast in to Sales –
with the result that the sales and profits progress is very sluggish. However,
long term Investors can hope to reap good benefits from this share.
Results Table
|
Venus
Remedies
|
31-Dec-13
|
30-Sep-13
|
QoQ%
Dif
|
31-Dec-12
|
YoY%
Dif
|
|
Net
Sales
|
13022.3
|
12452.8
|
4.57
|
11162.4
|
16.66
|
|
Total
Expenditure
|
10517.3
|
10253.1
|
2.58
|
9074.3
|
15.9
|
|
Profit
before Intt, Dep. & Taxes
|
2505
|
2199.7
|
13.88
|
2088.1
|
19.97
|
|
Net
Profit
|
1722.8
|
1499.7
|
14.88
|
1605.5
|
7.31
|
|
Diluted
EPS
|
15.06
|
13.11
|
14.87
|
-
|
|
|
Total
Income
|
13126.1
|
12524.3
|
4.81
|
11263.6
|
16.54
|
|
Changes
in inventories
|
-75.3
|
225.1
|
-133.45
|
5.5
|
-1469.09
|
|
Cost
of materials
|
7024.1
|
7041.2
|
-0.24
|
6353.5
|
10.55
|
|
Employee
benefits
|
599.5
|
596.6
|
0.49
|
583.5
|
2.74
|
|
Depreciation
|
971.7
|
968.7
|
0.31
|
800.9
|
21.33
|
|
Other
expenses
|
1997.3
|
1421.5
|
40.51
|
1330.9
|
50.07
|
|
Total
expenses
|
10517.3
|
10253.1
|
2.58
|
9074.3
|
15.9
|
|
Profit
before tax
|
1781.6
|
1581.2
|
12.67
|
1694.4
|
5.15
|
|
Tax
Expenses
|
58.8
|
81.5
|
-27.85
|
88.9
|
-33.86
|
|
Net
Profit
|
1722.8
|
1499.7
|
14.88
|
1605.5
|
7.31
|
|
Face
Value (Rs )
|
10
|
10
|
0
|
0
|
|
|
Paid-up
Equity
|
1144.2
|
1144.2
|
0
|
974.2
|
17.45
|
|
Basic
EPS
|
15.06
|
13.11
|
14.87
|
16.48
|
-8.62
|
|
Public
holding (%)
|
56.26
|
56.26
|
0
|
66.08
|
-14.86
|
*
* * E
N D *
* *
No comments:
Post a Comment